Sharepoint Solutions
PRODUCTS
-
Gain confidence in your clinical research data with direct data capture (DDC).
-
Discover better logistics support for the pharmaceutical, biotechnology, and medical device industries with high-quality kit packing and distribution through in-house kit-building facilities.
-
A global team of trusted experts for multi-phase clinical development.
-
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
Reduce manual validation efforts, cut costs by up to 30%, get new products out the door faster, and enable seamless regulatory inspections.
WHITE PAPERS AND CASE STUDIES
-
The Patient Recruitment Shift: Navigating Disruption, Delivering Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Response To FDA Black Box Warning
The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.
-
Advancing Oncology Innovation With Adaptive Trial Designs
When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
Overcoming Known Pharmacological Effects
Uncover how our team was able to address the challenges of evaluating treatments that reduce food consumption and cause body weight loss while ensuring animal health and study integrity.
-
PEG In LNP Formulations: Addressing Challenges And Seeking Solutions
Polyethylene glycol and similar variants have driven innovative research for therapies. However, the continued use of PEG poses significant drawbacks.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
Predictive Modeling Of Transmitted Wavefront Error In High-Performance Optical Coatings
When interferometric testing isn’t possible, an analytical, spectral-based model predicts coating-contributed transmitted wavefront error with confidence, enabling compliance and control for advanced optical systems.
-
AMERICAN Plays A Role In Rebuilding Puerto Rico's Infrastructure
AMERICAN is helping rebuild Puerto Rico’s vital water infrastructure after Hurricane Maria, supplying American-made products to strengthen resiliency for 3.5 million residents and millions of annual visitors.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
NEWS
-
CSU And EPA Partner To Expand Water Data Access10/2/2025
The Radical Open Science Syndicate (ROSS) — a watershed data science lab in the Warner College of Natural Resources — partnered with the U.S. Environmental Protection Agency to improve water data access through Tools for Automated Data Analysis, or TADA, a toolkit empowering water resource managers to use the data they collect.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
'A More Versatile And Powerful Foundation For Future Photonic Technologies'6/24/2025
The candidate pool for engineered materials that can help enable tomorrow’s cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.
-
Study To Determine Most Effective PFAS Treatments For High-Risk Homes3/2/2026
Research to fill key knowledge gaps on the effectiveness of household water treatment systems for PFAS and other fluorinated organic compounds is under way under the direction of Assistant Professor Dr. Riley Mulhern of the University of Colorado Boulder.
-
Huachen AI Parking Management Technology Holding Co., Ltd. Expands Smart City Ecosystem With Launch Of 4G Smart Energy Management And Green Power Arbitrage Initiative2/2/2026
Huachen AI Parking Management Technology Holding Co., Ltd. (NASDAQ: HCAI, “Huachen” or the “Company”), a China-based smart-parking and equipment-structural-parts provider in China, today announced the strategic expansion of its Smart City ecosystem with the launch of its 4G Smart Energy Management and Green Power Arbitrage Initiative.